4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-050043
Chief Scientific Officer sold 3,000 shares at an average $83.07 ($249,215)
- Chief Scientific Officer acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Biller Scott Chief Scientific Officer | 2018-09-05 | Option exercise | +3,000 | $9.05 | $27,150 | 60,196 | D |
| Biller Scott Chief Scientific Officer | 2018-09-05 | Sale | −640 | $82.52 | $52,813 | 59,556 | D |
| Biller Scott Chief Scientific Officer | 2018-09-05 | Sale | −2,260 | $83.17 | $187,964 | 57,296 | D |
| Biller Scott Chief Scientific Officer | 2018-09-05 | Sale | −100 | $84.38 | $8,438 | 57,196 | D |
| Derivatives | |||||||
| Biller Scott Chief Scientific Officer | 2018-09-05 | Option exercise · Stock options (right to buy) | −3,000 | 10,154 | D | ||
| Open-market sales · 3,000 sh · avg $83.07 · $249,215 | |||||||
Loading xslF345X03/doc4.xml…